The biological role and regulation of versican levels in cancer
暂无分享,去创建一个
D. Horsfall | C. Ricciardelli | D. Russell | M. Ween | Carmela Ricciardelli | Andrew J. Sakko | Miranda P. Ween | Darryl L. Russell | David J. Horsfall | A. Sakko
[1] C. Bandtlow,et al. Brain derived versican V2 is a potent inhibitor of axonal growth. , 2000, Journal of cell science.
[2] J. Couchman,et al. Association of versican with dermal matrices and its potential role in hair follicle development and cycling. , 1995, The Journal of investigative dermatology.
[3] T. Wight,et al. Versican degradation and vascular disease. , 2006, Trends in cardiovascular medicine.
[4] P. Katonis,et al. Regulation of hyaluronan and versican deposition by growth factors in fibrosarcoma cell lines. , 2008, Biochimica et biophysica acta.
[5] E. Schönherr,et al. Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. , 1991, The Journal of biological chemistry.
[6] M. Mörgelin,et al. Distribution of PG-M/Versican Variants in Human Tissues andde Novo Expression of Isoform V3 upon Endothelial Cell Activation, Migration, and Neoangiogenesis in Vitro * , 2002, The Journal of Biological Chemistry.
[7] D Heinegård,et al. The Proteoglycans Aggrecan and Versican Form Networks with Fibulin-2 through Their Lectin Domain Binding* , 2001, The Journal of Biological Chemistry.
[8] T. Wight,et al. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[9] J. Nakamura,et al. Glioma invasiveness responds variably to irradiation in a co-culture model. , 2007, International journal of radiation oncology, biology, physics.
[10] S. Hockfield,et al. Brain-enriched Hyaluronan Binding (BEHAB)/Brevican Cleavage in a Glioma Cell Line Is Mediated by a Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS) Family Member* , 2000, The Journal of Biological Chemistry.
[11] Pier Andrea Nicolosi,et al. Proteoglycans in the Control of Tumor Growth and Metastasis Formation , 2008, Connective tissue research.
[12] A. Bosserhoff,et al. The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-β2 , 2007, British Journal of Cancer.
[13] Yaou Zhang,et al. The G3 Domain of Versican Enhances Cell Proliferation via Epidermial Growth Factor-like Motifs* , 1998, The Journal of Biological Chemistry.
[14] A. Colombatti,et al. The globular domains of PGM/versican modulate the proliferation‐apoptosis equilibrium and invasive capabilities of tumor cells , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] M. Waters,et al. Growth factor modulation of mitogenic responses and proteoglycan synthesis by human periodontal fibroblasts , 1998, Journal of cellular physiology.
[16] R. Contreras,et al. Differentiation of EL4 lymphoma cells by tumoral environment is associated with inappropriate expression of the large chondroitin sulfate proteoglycan PG‐M and the tumor‐associated antigen HTgp‐175 , 1998, International journal of cancer.
[17] William Arbuthnot Sir Lane,et al. Glial hyaluronate-binding protein: a product of metalloproteinase digestion of versican? , 1995, The Biochemical journal.
[18] M. Akens,et al. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis , 2007, Breast Cancer Research.
[19] S. Mukaratirwa,et al. Mutual paracrine effects of colorectal tumour cells and stromal cells: modulation of tumour and stromal cell differentiation and extracellular matrix component production in culture , 2005, International journal of experimental pathology.
[20] Jiaquan Xu,et al. Deaths: final data for 2005. , 2008, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[21] G. Miserocchi,et al. The sensitivity of versican from rabbit lung to gelatinase A (MMP‐2) and B (MMP‐9) and its involvement in the development of hydraulic lung edema , 1999, FEBS letters.
[22] Shuhei Yamada,et al. Oversulfated Chondroitin/Dermatan Sulfates Containing GlcAβ1/IdoAα1–3GalNAc(4,6-O-disulfate) Interact with L- and P-selectin and Chemokines* , 2002, The Journal of Biological Chemistry.
[23] K. Almholt,et al. Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer model , 2008, Molecular Cancer Therapeutics.
[24] D. Horsfall,et al. Expression of Extracellular Matrix Components Versican, Chondroitin Sulfate, Tenascin, and Hyaluronan, and Their Association with Disease Outcome in Node-Negative Breast Cancer , 2004, Clinical Cancer Research.
[25] A. Scarpa,et al. Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] Peter Beighton,et al. de la Chapelle, A. , 1997 .
[27] I. Stamenkovic,et al. Inhibition of tumor growth in vivo by hyaluronan oligomers , 1998, International journal of cancer.
[28] A. Skubitz,et al. Cell membrane glycosylation mediates the adhesion, migration, and invasion of ovarian carcinoma cells , 2004, Clinical & Experimental Metastasis.
[29] D. Kletsas,et al. The greatly increased amounts of accumulated versican and decorin with specific post-translational modifications may be closely associated with the malignant phenotype of pancreatic cancer. , 2006, Biochimica et biophysica acta.
[30] W. Knudson,et al. Assembly of a chondrocyte-like pericellular matrix on non-chondrogenic cells. Role of the cell surface hyaluronan receptors in the assembly of a pericellular matrix. , 1991, Journal of cell science.
[31] S. Shapiro,et al. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[32] D. Horsfall,et al. Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[33] E. De Pauw,et al. Identification of specific reachable molecular targets in human breast cancer using a versatile ex vivo proteomic method , 2007, Proteomics.
[34] S. Hockfield,et al. BEHAB (brain enriched hyaluronan binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines. , 1996, Cancer research.
[35] A. Yee,et al. The interaction of versican with its binding partners , 2005, Cell Research.
[36] D. Horsfall,et al. Formation of Hyaluronan- and Versican-rich Pericellular Matrix by Prostate Cancer Cells Promotes Cell Motility* , 2007, Journal of Biological Chemistry.
[37] D. Horsfall,et al. Changes in steroid receptors and proteoglycan expression in the guinea pig prostate stroma during puberty and hormone manipulation , 2007, The Prostate.
[38] F. Wright,et al. Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[39] S. Allahverdian,et al. Androgen Receptor Regulation of the Versican Gene through an Androgen Response Element in the Proximal Promoter* , 2007, Journal of Biological Chemistry.
[40] A. Bassols,et al. Versican is differentially expressed in human melanoma and may play a role in tumor development. , 2002, The American journal of pathology.
[41] R. DePinho,et al. Genetics and biology of pancreatic ductal adenocarcinoma , 2006, Genes & development.
[42] S. Ochsner,et al. Hormone-regulated expression and localization of versican in the rodent ovary. , 2003, Endocrinology.
[43] V. Kosma,et al. High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma , 2006, Journal of Clinical Pathology.
[44] 松本 和. Distinct interaction of versican/ PG-M with hyaluronan and link protein , 2004 .
[45] J. Sandy,et al. ADAMTS4 (aggrecanase-1) cleaves human brain versican V2 at Glu405-Gln406 to generate glial hyaluronate binding protein. , 2004, The Biochemical journal.
[46] J. Kirkwood,et al. Integrins and cancer. , 2007, Oncology.
[47] A. Bassols,et al. V3 versican isoform expression has a dual role in human melanoma tumor growth and metastasis , 2006, Laboratory Investigation.
[48] E. Ruoslahti,et al. Multiple domains of the large fibroblast proteoglycan, versican. , 1989, The EMBO journal.
[49] Alfonso Bellacosa,et al. Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways , 2005, Oncogene.
[50] K. Tashiro,et al. Versican Interacts with Chemokines and Modulates Cellular Responses* , 2001, The Journal of Biological Chemistry.
[51] G. Maira,et al. Invasive tumor cells and prognosis in a selected population of patients with glioblastoma multiforme , 2008, Cancer.
[52] V. Lee,et al. Versican enhances locomotion of astrocytoma cells and reduces cell adhesion through its G1 domain. , 1999, Journal of neuropathology and experimental neurology.
[53] A. Miller-Larsson,et al. Lung fibroblast proteoglycan production induced by serum is inhibited by budesonide and formoterol. , 2006, American journal of respiratory cell and molecular biology.
[54] J. Fischer,et al. Versican V1 Proteolysis in Human Aorta in Vivo Occurs at the Glu441-Ala442 Bond, a Site That Is Cleaved by Recombinant ADAMTS-1 and ADAMTS-4* , 2001, The Journal of Biological Chemistry.
[55] M. Mörgelin,et al. Avian neural crest cell migration is diversely regulated by the two major hyaluronan-binding proteoglycans PG-M/versican and aggrecan. , 2000, Development.
[56] R. Tibshirani,et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[57] T. Wight,et al. Versican: a versatile extracellular matrix proteoglycan in cell biology. , 2002, Current opinion in cell biology.
[58] S. Hockfield,et al. BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion , 2008, Journal of Neuro-Oncology.
[59] Anthony J. Guidi,et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[60] K. Nabeshima,et al. Cohort migration of carcinoma cells: differentiated colorectal carcinoma cells move as coherent cell clusters or sheets. , 1999, Histology and histopathology.
[61] M. Iruela-Arispe,et al. Proteolytic cleavage of versican during cardiac cushion morphogenesis , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.
[62] D. Zimmermann,et al. Characterization of the complete genomic structure of the human versican gene and functional analysis of its promoter. , 1994, The Journal of biological chemistry.
[63] H. Larjava,et al. Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-beta 1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture. , 1991, The Journal of biological chemistry.
[64] V. Kosma,et al. Versican in epithelial ovarian cancer: Relation to hyaluronan, clinicopathologic factors and prognosis , 2003, International journal of cancer.
[65] B. McManus,et al. Versican: signaling to transcriptional control pathways. , 2006, Canadian journal of physiology and pharmacology.
[66] N. Karamanos,et al. Proteoglycans in human malignant mesothelioma. Stimulation of their synthesis induced by epidermal, insulin and platelet-derived growth factors involves receptors with tyrosine kinase activity. , 1999, Biochimie.
[67] F. Hamdy,et al. The expression and regulation of ADAMTS‐1, ‐4, ‐5, ‐9, and ‐15, and TIMP‐3 by TGFβ1 in prostate cells: relevance to the accumulation of versican , 2005, The Prostate.
[68] R. Page,et al. Interleukin-1 beta regulation of fibroblast proteoglycan synthesis involves a decrease in versican steady-state mRNA levels. , 1993, The Biochemical journal.
[69] A. Alexandrova,et al. Evolution of cell interactions with extracellular matrix during carcinogenesis , 2008, Biochemistry (Moscow).
[70] R. Fritsche-Danielson,et al. Role of ADAMTS-1 in atherosclerosis: remodeling of carotid artery, immunohistochemistry, and proteolysis of versican. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[71] D. Horsfall,et al. Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[72] J. Lemire,et al. Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro , 2002, Journal of cellular physiology.
[73] D. Horsfall,et al. Modulation of prostate cancer cell attachment to matrix by versican. , 2003, Cancer research.
[74] A. Hongo,et al. Prognostic significance of stromal versican expression in human endometrial cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[75] V. Kosma,et al. Versican expression in pharyngeal squamous cell carcinoma: an immunohistochemical study , 2004, Journal of Clinical Pathology.
[76] M. Yamagata,et al. Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG-M/versican. , 1994, Journal of cell science.
[77] M. Yamagata,et al. Chondroitin sulfate proteoglycan (PG-M-like proteoglycan) is involved in the binding of hyaluronic acid to cellular fibronectin. , 1986, The Journal of biological chemistry.
[78] Christina K. Chan,et al. Interleukin-1beta selectively decreases the synthesis of versican by arterial smooth muscle cells. , 2007, Journal of cellular biochemistry.
[79] F. Lu,et al. Versican V1 isoform induces neuronal differentiation and promotes neurite outgrowth. , 2004, Molecular biology of the cell.
[80] A. Bassols,et al. V3 versican isoform expression alters the phenotype of melanoma cells and their tumorigenic potential , 2005, International journal of cancer.
[81] E. Schönherr,et al. Genistein selectively inhibits platelet-derived growth factor-stimulated versican biosynthesis in monkey arterial smooth muscle cells. , 1997, Archives of biochemistry and biophysics.
[82] David E. Misek,et al. Analysis of Tumor-Host Interactions by Gene Expression Profiling of Lung Adenocarcinoma Xenografts Identifies Genes Involved in Tumor Formation , 2005, Molecular Cancer Research.
[83] Jonathan R Pollack,et al. A transcriptional response to Wnt protein in human embryonic carcinoma cells , 2002, BMC Developmental Biology.
[84] A. Skubitz,et al. Establishment of an in vitro assay to measure the invasion of ovarian carcinoma cells through mesothelial cell monolayers , 2004, Clinical & Experimental Metastasis.
[85] Yaou Zhang,et al. Cell adhesion and proliferation mediated through the G1 domain of versican , 1999, Journal of cellular biochemistry.
[86] M. Miyasaka,et al. Binding of a Large Chondroitin Sulfate/Dermatan Sulfate Proteoglycan, Versican, to L-selectin, P-selectin, and CD44* , 2000, The Journal of Biological Chemistry.
[87] A. Theocharis,et al. Large matrix proteoglycans, versican and perlecan, are expressed and secreted by human leukemic monocytes. , 2003, Anticancer research.
[88] V. Kosma,et al. Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis. , 2005, Human pathology.
[89] J. Fawcett,et al. Versican Is Upregulated in CNS Injury and Is a Product of Oligodendrocyte Lineage Cells , 2002, The Journal of Neuroscience.
[90] T. Wight,et al. Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells. , 2001, Archives of biochemistry and biophysics.
[91] W. Paulus,et al. Differential Expression of Versican Isoforms in Brain Tumors , 1996, Journal of neuropathology and experimental neurology.
[92] R. Timpl,et al. Fibulin-1 Is a Ligand for the C-type Lectin Domains of Aggrecan and Versican* , 1999, The Journal of Biological Chemistry.
[93] S. Paris,et al. Hyaluronectin modulation of lung metastasis in nude mice. , 2006, European journal of cancer.
[94] S. Baylin,et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. , 1999, Cancer research.
[95] T. Ratliff. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. , 2005, The Journal of urology.
[96] T. Oegema,et al. Hyaluronan Synthase Elevation in Metastatic Prostate Carcinoma Cells Correlates with Hyaluronan Surface Retention, a Prerequisite for Rapid Adhesion to Bone Marrow Endothelial Cells* , 2001, The Journal of Biological Chemistry.
[97] H K Dressman,et al. Identification of genes associated with ovarian cancer metastasis using microarray expression analysis , 2006, International Journal of Gynecologic Cancer.
[98] E. Ruoslahti,et al. The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[99] A. Tsatsakis,et al. Transforming Growth Factor‐β as a key molecule triggering the expression of versican isoforms v0 and v1, Hyaluronan Synthase‐2 and synthesis of Hyaluronan in Malignant Osteosarcoma cells , 2006 .
[100] Peter Friedl,et al. Tube travel: the role of proteases in individual and collective cancer cell invasion. , 2008, Cancer research.
[101] J. Slingerland,et al. The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis. , 2005, Molecular biology of the cell.
[102] Burton B. Yang,et al. β1-Integrin-mediated Glioma Cell Adhesion and Free Radical-induced Apoptosis Are Regulated by Binding to a C-terminal Domain of PG-M/Versican* , 2002, The Journal of Biological Chemistry.
[103] A. J. Day,et al. Selective inhibition of ADAMTS-1, -4 and -5 by catechin gallate esters. , 2003, European journal of biochemistry.
[104] S. Ochsner,et al. Processing and Localization of ADAMTS-1 and Proteolytic Cleavage of Versican during Cumulus Matrix Expansion and Ovulation* , 2003, Journal of Biological Chemistry.
[105] D. Horsfall,et al. Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non‐organ confined disease , 2005, The Prostate.
[106] Maree H. Poniris,et al. A phosphodiesterase 4 inhibitor inhibits matrix protein deposition in airways in vitro. , 2006, The Journal of allergy and clinical immunology.
[107] Freddie C Hamdy,et al. Screening for prostate cancer: an update. , 2008, European urology.
[108] H. Friess,et al. Pancreatic tumor cells influence the composition of the extracellular matrix. , 2004, Biochemical and biophysical research communications.
[109] Burton B. Yang,et al. The ability of versican to simultaneously cause apoptotic resistance and sensitivity. , 2007, Cancer research.
[110] K. Kurth,et al. Role of proteoglycans in cell adhesion of prostate cancer cells: From review to experiment , 2004, Urological Research.
[111] M. Yamagata,et al. Selective distributions of proteoglycans and their ligands in pericellular matrix of cultured fibroblasts. Implications for their roles in cell-substratum adhesion. , 1993, Journal of cell science.
[112] H. Sasamura,et al. Regulation of vascular proteoglycan synthesis by angiotensin II type 1 and type 2 receptors. , 2001, Journal of the American Society of Nephrology : JASN.
[113] T. Wight,et al. Regulation of Proteoglycan Synthesis by Leukotriene D4 and Epidermal Growth Factor in Bronchial Smooth Muscle Cells Materials and Methods , 2022 .
[114] S. Berceli,et al. Increased Plasmin and Serine Proteinase Activity During Flow-Induced Intimal Atrophy in Baboon PTFE Grafts , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[115] R. Ádány,et al. Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels. , 1990, The Journal of biological chemistry.
[116] G. Westergren-Thorsson,et al. Alteration of proteoglycan synthesis in human lung fibroblasts induced by interleukin‐1β and tumor necrosis factor‐α , 2000, Journal of cellular biochemistry.
[117] S. Hockfield,et al. Glial Tumor Invasion: A Role for the Upregulation and Cleavage of BEHAB/Brevican , 2001, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[118] N. Nakashima,et al. Immunohistochemical localization of extracellular matrix components in human breast tumours with special reference to PG- M/versican , 2004, The Histochemical Journal.
[119] M. Miyasaka,et al. Identification and characterization of ligands for L-selectin in the kidney. I. Versican, a large chondroitin sulfate proteoglycan, is a ligand for L-selectin. , 1999, International immunology.
[120] C. Burger,et al. Consequences of loss of progesterone receptor expression in development of invasive endometrial cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[121] D. Horsfall,et al. Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1. , 2001, Cancer research.
[122] E. Ruoslahti,et al. Hyaluronate binding properties of versican. , 1992, The Journal of biological chemistry.
[123] A. Hongo,et al. Versican expression in human cervical cancer. , 2007, European journal of cancer.
[124] B. McManus,et al. Regulation of the Versican Promoter by the β-Catenin-T-cell Factor Complex in Vascular Smooth Muscle Cells* , 2005, Journal of Biological Chemistry.
[125] Sabrina Cattaruzza,et al. Proteoglycan control of cell movement during wound healing and cancer spreading. , 2005, Matrix biology : journal of the International Society for Matrix Biology.
[126] R. Kerbel,et al. Versican/PG‐M G3 domain promotes tumor growth and angiogenesis , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[127] M. Stack,et al. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion , 2007, Nature Cell Biology.
[128] Christina K. Chan,et al. Interleukin‐1β selectively decreases the synthesis of versican by arterial smooth muscle cells , 2007 .